ChemoSapiens
PrivateLast Round
Grant
May 9, 2024
Total Funding Raised
$182,000
Company Overview
ChemoSapiens operates in Healthcare & Life Sciences and is based in Santiago de Compostela. Its latest recorded funding round was a Grant round in May 2024.
ChemoSapiens is a biotechnology company that operates an advanced marketplace for chemical reagents, allowing researchers to compare and purchase from multiple suppliers.
Sector
Healthcare & Life Sciences
Verticals
E-commerce, Pharma Supply Chain, Supply Chain, Biotech Equipment
Business Model
B2B
Customer Profile
Marketplace Commission, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ChemoSapiens Comparables
Compare ChemoSapiens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Labscoop | 81% | |
| Zageno | 77% | |
| Labviva | 77% |
For institutional investors. Book with your work email.
ChemoSapiens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 9, 2024 | ||||
| Accelerator | Nov 4, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ChemoSapiens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioIncubaTech | Accelerator |
| Agencia Gallega de Innovación | Grant |
| Empresa Nacional de Innovación | Debt |
| Instituto Galego de Promoción Económica | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 4, 2020
Accelerator round led by BioIncubaTech
For institutional investors. Book with your work email.
ChemoSapiens Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ChemoSapiens's valuation, stock price, and market status.
Is ChemoSapiens a public or private company?
ChemoSapiens is a private company.
What is the current stock price of ChemoSapiens?
ChemoSapiens is a private company, so its shares have no public market price. Caplight tracks ChemoSapiens's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ChemoSapiens worth (valuation)?
Valuation information for ChemoSapiens is not publicly available.
Can I buy ChemoSapiens stock?
ChemoSapiens shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ChemoSapiens's last funding round?
ChemoSapiens's most recent funding round was Grant on May 9, 2024.
Who are the main investors in ChemoSapiens?
Key investors in ChemoSapiens include BioIncubaTech.
Will ChemoSapiens IPO soon?
No public IPO plans have been announced for ChemoSapiens.
How can I track ChemoSapiens secondary market activity?
Caplight tracks bids, offers, and trades in ChemoSapiens's shares on secondary markets.